grant – SYGNOMICS Precision Medicine

Sygnomics lands $2 million grant to advance personalized precision oncology solutions.

The Andy Hill Cancer Research Endowment (CARE) Fund awarded a $2 million Life Science

By sygnomics_adm|2023-10-18T22:38:59+00:00October 18th, 2023|News|0 Comments

WRF gives ISB a Phase 2 gift to advance clinical validations of SYGNAL technology

By sygnomics_adm|2023-01-17T20:21:26+00:00June 20th, 2020|News|0 Comments

WRF gives ISB a Phase 1 gift to explore commercialization potential for SYGNAL

By sygnomics_adm|2023-01-17T20:20:27+00:00January 17th, 2019|News|0 Comments